Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: A validated cellular biobank for β-thalassemia

Fig. 3

a Representative experiment showing the variation of expression of the hematopoietic stem cell marker CD117, adhesion molecule marker CD44, beta1-integrin surface marker CD29, and erythroid differentiation marker CD235 (GPA) in undifferentiated cells (day 0) and in cells at two progressive stages of erythroid maturation (day 4 and 8). bi Quantitative data showing the % of cells expressing the indicated markers (be) and the mean fluorescence values (MF) (fi) after FACS analyses using antibodies recognizing CD117 (b, f), CD44 (c, g), CD29 (d, h) and GPA (e, i). The data represent the average ±SD obtained in seven independent experiments using vials obtained from 7 different β-thalassemia patients

Back to article page